The U.S. Food and Drug Administration has permitted marketing of two catheter-based devices designed to create an arteriovenous (AV) fistula in patients with chronic kidney disease in need of hemodialysis. The devices are designed […]
The National Institute for Health and Care Excellence has concluded that Roche’s Ocrevus should not be funded on the NHS for the treatment of primary progressive multiple sclerosis (PPMS) in adults.In draft guidelines, the committee […]
Roche has unveiled data showing that a combination of Tecentriq and Abraxane significantly slashed the risk of disease worsening or death in some breast cancer patients. According to the drug giant, the IMpassion130 study […]
Pfizer Inc. announced today that the European Commission (EC) has approved XELJANZ® 5 mg twice daily in combination with methotrexate for the treatment of active psoriatic arthritis in adult patients who have had an inadequate […]
A cannabis-derived medicine has been approved for the first time by the US Food and Drug Administration (FDA).The approval was granted to Greenwich Biosciences, the US subsidiary of GW Pharmaceuticals, for Epidiolex, an oral solution […]